AI guides Doctors' lungs scope in pneumonia battle

NCT ID NCT07230431

Not yet recruiting Diagnosis Sponsor: Chinese Medical Association Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests an AI system that helps doctors navigate a bronchoscope (a thin tube with a camera) into the lungs of patients with severe pneumonia. The AI provides real-time visual cues and voice prompts to guide the doctor to the right spot and describe what they see. About 100 adults will take part across multiple hospitals in China. The goal is to see if AI assistance improves diagnostic accuracy and reduces procedure time compared to standard bronchoscopy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Embodied-Intelligence-Assisted Bronchoscopy Navigation and Diagnostic System (EIBRONCH) - an AI software/hardware device that provides real-time visual and voice guidance during bronchoscopy
What this could lead to: If successful, this AI system could help doctors perform bronchoscopy more accurately and quickly, potentially improving diagnosis and treatment for severe pneumonia patients.
What could go wrong: This is an early-stage study with only 100 participants, so results may not apply to all patients. The AI is decision-support only, and technical issues or user error could limit its benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PNEUMONIA RESPIRATORY FAILURE (PEDIATRIC PATIENTS)

More trials for these conditions

Other studies related to the condition(s) this trial covers.